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SCIENTIFIC CORRESPONDENCE
Mechanical endonasal dacryocystorhinostomy with
mucosal flaps
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Aims: To describe and assess the efficacy of mechanical
endonasal dacryocystorhinostomy (MENDCR). This is a
new technique that involves creation of a large rhinostomy
and mucosal flaps. The study involved a prospective non-
randomised interventional case series with short peri-
operative follow up.
Method: A prospective series of 104 consecutive endona-
sal DCRs performed from January 1999 to December
2001 were entered into the study. Patients included in the
study had nasolacrimal duct obstruction and had not had
previous lacrimal surgery. The technique involved anasto-
mosis of nasal mucosal and lacrimal sac flaps and a large
bony ostium. Surgery was performed by two surgeons
(AT/PJW). Follow up assessment included nasoendoscopy
as well as symptom evaluation. Success was defined as
anatomical patency with fluorescein flow on nasoendos-
copy and patency to lacrimal syringing. The average
follow up time was 9.7 months (range 2–28, SD 6.7
months).
Results: There were 104 DCRs performed on 86 patients
(30 male, 56 female). The average age of the patients was
59 years (range 3–89, SD 24.1 years). Common presen-
tations were epiphora (77%) and/or mucocele (19%).
Septoplasty (SMR) was required in 48 DCRs (46%) and 13
DCRs (12.5%) needed other endoscopic surgery in
conjunction with the lacrimal surgery. The surgery was suc-
cessful in 93 cases (89%). Of the 11 cases that were clas-
sified as a failure six patients was anatomically patent but
still symptomatic and another two had preoperative canal-
icular problems. The anatomical patency with this new
technique was thus 95% (99 of 104 DCRs).
Conclusion: MENDCR involves creation of a large ostium
and mucosal preservation for the construction of flaps. The
anatomical success is 95% and is similar to external DCR
and better then other endonasal approaches. The authors
suggest that creation of a large ostium as well as mucosal
flaps improves the efficacy of this endonasal technique.
Dacryocystorhinostomy (DCR) is an operation that hasbeen used for the past 100 years. The original intranasalapproach was described in 1893 by Caldwell1 and the
external approach in 1904 by Toti.2 The external approach
became very popular and the mainstay of treatment with modi-
fication in the 1920s3 with the addition of flaps, and in 1962
with silastic tube intubation by Jones.4 The intranasal approach
was largely abandoned owing to problems with visualisation
but with modern endoscopes and rhinology instruments there
has been renewed interest in the past 10 or so years.McDonogh
and Meiring5 described the first modern endonasal DCR proce-
dure in 1989 withMassaro et al6 in 1990 using an argon laser for
the osteotomy. In 1991 Gonnering et al7 used an endoscope with
the argon laser, rather than the operating microscope, for com-
pleting the endonasal procedure.
Many ophthalmologists still believe that external DCR is
the gold standard treatment for nasolacrimal duct obstruction
(NLDO)8 with success rates of 90%+ reported.9
Currently endoscopic DCR can be performed with laser
assistance10 11 or other methods to remove bone and mucosa
including powered drills,12 punches,13 and radio surgical
electrodes.14 Laser assisted DCR (ENLDCR) has success rates
which vary from 60% to 86%,10 11 whereas endonasal DCR with
other tools (“cold steel”) seems to have a slightly higher suc-
cess rate.12 13
Most previous procedures involved sacrificing the nasal
mucosa and removing the medial wall of the sac. We describe
an approach that involves preservation of nasal mucosa and
the cutting of anterior and posterior flaps in the lacrimal sac in
order to achieve mucosal and lacrimal sac anastomosis at the
end of the procedure. The flaps are not sutured but closely
apposed. This leads to the marsupialisation of the sac on the
lateral nasal wall rather than creation of an ostium into the
sac. To achieve lacrimal sac marsupialisation complete
exposure of the sac is necessary. Until a recent publication15
the intranasal anatomy of the lacrimal sac was not fully
understood.16 The upper half of the sac lies above the insertion
of the middle turbinate on the lateral nasal wall. This puts it
behind the thick bone of the frontal process of the maxilla. To
fully expose this area the use of a drill is necessary. Only the
inferior posterior part of the sac is covered by the thin lacrimal
bone.
MATERIALS AND METHODS
Consecutive patients undergoing primary DCR from January
1999 to December 2001 were included in the study. Patients’
standard preoperative evaluation included investigation using
lacrimal irrigation. Jones test and endoscopy of the nasal cav-
ity were also performed. Dacryocystography and lacrimal
scintillography was done on all patients. It was possible to
assess the need for concurrent septoplasty (SMR) preopera-
tively. If the middle turbinate is not visible with the endoscope
preoperatively owing to a septal deviation or spur then access
is tight and DCR with septoplasty is needed. A large capacious
nasal cavity with easy view of middle turbinate suggests
MENDCR can be performed without SMR. Any lower lid
problems or previous lacrimal trauma were exclusion criteria.
There were 86 patients who underwent 104 endoscopic DCR
procedures all using the same technique performed by two
main surgeons (PJW, AT). Thirty nine patients had a left DCR,
29 a right DCR, and 18 patients bilateral DCRs. There were 56
female and 30 male patients aged 59 years (range 3–89, SD
24.1). Acute or chronic dacryocystitis was a feature in 14% of
patients and mucocoele in 20% (Table 1).
Patients who required other nasal procedures were included
in the analysis. These included septoplasty (SMR), which was
often necessary to perform the DCR, as well as other
endoscopic surgery. Middle meatal antrostomy for sinus
disease was the commonest ancillary procedure performed.
Infrequently, uncinectomy or inferior turbinectomy was
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performed. Some patients in this analysis have been included
in a previous pilot study.17 Informed consent was obtained
from all patients
Surgical technique
The nasal mucosa was decongested with pledgets soaked in
10% cocaine. The lateral nasal wall and head of the middle
turbinate (MT) were injected with local anaesthetic (2% Xylo-
caine with 1:80 000 adrenaline (Astra Pharmaceuticals, N
Ryde, Sydney, Australia)). The 30° Storz (Storz, St Louis, MI,
USA) endoscope with three chip camera was used for the
entire operation, except when a septoplasty was required in
which case the zero degree scope was used.
A mucosal flap, hinged posteriorly, was elevated from the
lateral nasal wall to expose the frontal process of the maxilla
and its articulation with the lacrimal bone. The incision for the
mucosal flap begins 8 mm above the insertion of the middle
turbinate and is brought horizontally forward 8 mm anterior
to the middle turbinate. It is taken vertically down to just
above the insertion of the inferior turbinate before taking it
posteriorly up to the insertion of the uncinate process. The
mucosal flap is elevated exposing the junction of the hard
frontal process of the maxilla and the thin soft lacrimal bone.
The lacrimal bone was peeled off the inferior half of the
lacrimal sac. A Hajek-Koeffler forward biting punch (Martin,
Tutligen, Germany) was then used to remove the frontal proc-
ess of the maxilla which overlies the anterior part of the infe-
rior lacrimal sac. The bone over the superior nasolacrimal duct
was also removed. Bone removal is continued superiorly till
the bone becomes too thick for the punch. A curved 15 degree
diamond burr attached to a powered microdebrider
(Medtronic Xomed, Jacksonville, FL, USA) is used to remove
the rest of the frontal process of the maxilla still covering the
anterior sac. This powered bone removal is continued superi-
orly above the attachment of the MT to remove bone that cov-
ers the fundus of the sac. Usually the agar nasi cell is exposed
as the fundus extends above the MT axilla. The entire sac
should be exposed. The medial wall of the sac is then tented
with a Bowman’s probe (Visitec, Warwickshire, UK) to ensure
all the bone over the common canalicular opening (CCO) has
been removed. It is important to ensure that all bone over the
CCO up to the fundus of the sac is removed, as this will allow
the sac flaps to sit flatter on the lateral nasal wall. The medial
wall of the sac is the incised vertically to create a large anterior
and smaller posterior flap. Small horizontal cuts are made in
these flaps superior and inferior so they can be reflected onto
the lateral nasal wall without any tension. Once the lacrimal
sac flaps have been positioned on the lateral nasal wall the
nasal mucosal flap is trimmed into a “C” shape. It forms a
superior and inferior flap extending anteriorly from the
posterior hinge. When reflected back onto the lateral nasal
wall the “C” shape of the nasal mucosal flaps fits around the
opened lacrimal sac so that the mucosal edges are closely
apposed. Usually only a small area of exposed bone anteriorly
on the frontal process of the maxilla is not covered by mucosa
(see Fig 1).
The lacrimal system is then intubated and a small gel foam
patch is used to keep the flap anastomosis in position for the
initial healing period. Postoperatively, oral antibiotics for 5
days (amoxicillin and clavulanic acid 500/125 three times
daily) and topical antibiotics (chloramphenicol drops) were
given. A saline moisturising spray was also used for 6 weeks to
help stop mucosal drying in the acute postoperative period. All
surgery was performed on a day case, outpatient basis. Follow
up of patients was at 1, 3, 6, 12, 24, and 39 months with the
average follow up being 9.7 months (2–28 months) after
removal of tubes. All except two patients received intubation.
Tubes were usually removed at the first postoperative visit at
4–8 weeks. Average intubation time was 6.1 weeks (range
2–52 weeks, SD 7.1 weeks).
Most patient underwent surgery with general anaesthesia
(81 of 86 patients). In 101 of the 104 DCR operations it was
possible to create a good sized opening in the lacrimal sac with
approximation of the flaps. After removal of tubes the patients
were assessed with rigid nasal endoscopy and fluorescein dye
passage. Morphological assessment of the ostium and syring-
ing of the lacrimal system was also done. Patients were
assessed in terms of anatomical patency as well as symptom
relief.
RESULTS
In the current study a well healed marsupialised ostium was
seen in 99 of 104 cases (95%). There was free flow to the nose
when one drop of 2% fluorescein was put in the conjunctival
sac. The nasolacrimal system was also patent to syringing via
the lacrimal puncta. In five of the 104 cases there was scarring
of the ostium at the sac-nasal mucosal anastomosis visible on
endoscopy. Neither fluorescein drainage nor lacrimal syring-
ing was possible. These five patients had epiphora similar to
their preoperative complaint. Six patients were symptomatic
with a patent system and a well healed ostium. Five of these
patients complained of epiphora preoperatively but were pat-
ent to syringing and on dacryocystography and one patient
had anatomical nasolacrimal duct obstruction preoperatively.
The overall success rate was then 89% (93 of 104 DCRs). All
these six patients showed a well healed ostium on endoscopy
but complained of occasional epiphora especially on windy
days. In these patients fluorescein was seen to drain into the
nose on endoscopy and lacrimal syringing was achieved with-
out undue pressure generation. Hence the anatomical success
rate was 99 of 104 case (95%) (Table 2).
Approximately 46% of cases (48 of 104) required a
septoplasty at the time of surgery which is higher than other
studies of endonasal DCR, but the creation of a large ostium
necessitates better access than is often required with other
procedures.18 19 About 12.5% of cases (13 of 104) required
endoscopic sinus surgery in conjunction with DCR, a rate seen
in other studies.20
There were three cases of postoperative haemorrhage. These
resolved with nasal packing and did not need transfusion. This
gives a rate of less than 3% which compares well with both
previous endonasal studies21 and external DCR studies.22 There






Operations/patients 43/37 48/38 13/11 104/86
Male 14 9 7 30
Female 23 29 4 56
Laterality of surgery
Left 20 16 3 39
Right 11 12 6 29
Bilateral 6 10 2 18
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were no cases of orbital fat exposure or frontal sinusitis which
can occur if the dissection is taken too posteriorly into the
uncinate.21 Damage to the orbital plate of the ethmoid (lamina
papyracea) and frontonasal duct can occur if the dissection is
taken too posterior.
In 102 of 104 cases O’Donohue tubes were used for lacrimal
intubation.
The average follow up was 9.7 months (range 2–28). Follow
up of these patients is still ongoing.
DISCUSSION
There has been concern over many years that endoscopic DCR
is not as successful as external DCR.8 23 24 There are very few
prospective randomised trials in the literature. A study by
Hartikainen et al9 in 1998 had a 1 year success rate of 75% for
endonasal DCR as opposed to 91% for conventional external
DCR. These investigators used non-laser tools to remove bone
in the lacrimal fossa. Other investigators in the literature have
used various lasers to create the rhinostomy.
Currently endonasal approaches can be divided into
endonasal laser assisted DCR (ENLDCR),7 25 endocanalicular
laser assisted DCR (ECLDCR),19 26 27 and powered mechanical
endonasal DCR (MENDCR), or “cold steel” DCR, with12 or
without drills.21 28
The present study has an anatomical success rate of 95%,
with success strictly defined in both anatomical and sympto-
matic terms. Patients were assessed for fluorescein drainage to
the nose when a drop was placed in the conjunctival sac. This
has been shown to be a good, accurate test for functional per-
formance of a patent DCR.29
The main difference between the presented technique and
previously described techniques is the creation of a large bony
ostium and mucosal apposition with the creation of mucosal
and lacrimal flaps.
Since the early 1990s laser assisted DCR (ENLDCR) has
grown in popularity but the long term success has not been
high enough to convince many ophthalmologists to adopt the
technique. The main problem with ENLDCR is the difficulty
removing the thick bone of the frontal process of the maxilla.
Figure 1 Mechanical endonasal DCR procedure. (A) A, frontal process of maxilla; B, nasal mucosal flap elevation. (B) Junction of frontal
process maxilla and lacrimal bone (arrow). (C) C, lateral nasal wall; black square, punch on frontal process of maxilla. (D) D, lacrimal sac;
arrowhead, nasal septum. (E) E, agar nasi cell; arrow, medial wall lacrimal sac, (F) F, opened lacrimal sac; asterisk, folding back of posterior
lacrimal sac flap.






Anatomical patency 99/104 (95%) 99/102 (97%)
Anatomical patency and symptom
relief
93/104 (89%) 93/102 (91%)
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Most lasers can only create a 5–8 mm osteotomy as they are
only removing the thin lacrimal bone at the posterior inferior
aspect of the lacrimal sac. Even though some authors30 have
suggested ostium size is unimportant we believe this is not the
case. The creation of a large ostium allows the room to fashion
an anastomosis of the lacrimal mucosa with the mucosa of the
nasal cavity. Anatomical studies15 have shown that the
lacrimal sac is lateral to the head of the middle turbinate
superiorly and its anteroinferior aspect is under the frontal
process of the maxilla (other investigators have placed the sac
lower on the lateral nasal wall).16 31 Both these areas have very
thick bone that is not amenable to removal by laser or
rongeurs. If an attempt is made to remove this thick bone with
a laser excessive heat is generated which may increase tissue
damage and postoperative scarring. This may be one of the
reasons for the decreased long term success of ENLDCR10 18 25
and ECLDCR.32 The technique described in this study uses
simple punches and a drill attached to a nasal microdebrider
to remove all the bone covering the lacrimal sac and upper part
of the nasolacrimal duct creating an osteotomy of around 20
mm × 15 mm. This is a much larger removal of bone than seen
in other endonasal approaches. The large osteotomy allows
wide exposure of the lacrimal sac and allows the creation of
mucosal flaps, which replicates nasal and sac mucosal apposi-
tion seen with external DCRs. A large ostium at the time of
surgery correlates with a large opening intranasally
postoperatively.33 Figure 2 shows a well marsupialised ostium.
It is important to note that much of the sac lies above the
level of the axilla of the middle turbinate,15 contrary to other
authors suggesting that the sac is anterior to or below the
insertion of the middle turbinate with little extension above
it.7 10 31 The bone covering this superior part of the sac is very
thick and has an intimate relation with the agar nasi cell
medially. In addition, it is important to recognise that the pos-
terior aspect of the lacrimal sac is adjacent to the
uncinate,34 35 and that this structure should be preserved.
Going posterior to this landmark leads to an increased risk of
orbital fat prolapse or haematoma12 in addition to compromis-
ing the natural ostium of the maxillary sinus. The uncinate
was preserved in all cases undergoing only a DCR and
removed only in patients who underwent additional endo-
scopic sinus surgery for chronic sinusitis not related to their
lacrimal symptoms. It has been suggested that the uncinec-
tomy needs to be done as the first step36 to endonasal DCR.
This is not necessary as the frontal process of the maxilla is a
constant intranasal landmark that abuts the thin lacrimal
bone below the insertion of the middle turbinate into the lat-
eral nasal wall. The junction of the hard frontal process of the
maxilla and the thin lacrimal bone is the first landmark that
is sought during the presented technique but it can only be
visualised with a 30 degree endoscope in the majority of
patients. The uncinate process is in a posterior relation to the
lacrimal bone and as such does not need removal to expose the
lacrimal sac. To fully expose the sac the thick bone of the fron-
tal process of the maxilla needs to be removed, as does the
bone superior to the lacrimal bone. This often necessitates
removal of the anterolateral wall of the agar nasi cell. Once the
sac is opened the common canalicular opening is used as a
landmark to ensure adequate exposure of the sac. It is impor-
tant to open the lacrimal sac with “cold steel” to avoid risks of
contracture and scarring.32 The creation of anterior and poste-
rior flaps in the lacrimal sac mucosa allows primary intention
healing with the nasal mucosal flaps, thus marsupialising the
sac into the lateral nasal wall. Poor or minimal preservation of
mucosa may lead to increased granulation and fibrosis.37 This
approach preserves the general principles of creating a
mucosal lined fistula so important in external DCR surgery.8
Postoperative scarring at the site of the rhinostomy is one of
the major causes of DCR failure,8 both with external and
ENLDCR38 39 techniques. In our current study five patients had
scarring of the osteotomy that led to failure of the surgery.
Several studies12 23 40 have suggested that a dependent ostium
position is vital to increase success in external and endonasal
surgery. Complete exposure and marsupialisation of the sac
with adequate bone removal obviates concern about ostium
position that may occur with other techniques. Recently
several investigators41 42 have used mitomycin C to improve
success rates with ENLDCR and some success rates seem close
to 100%.43 If the whole of the lacrimal sac is not exposed and
the rhinostomy is small this may have a future role in
preventing closure of the ostium.
Many studies of ENLDCR exclude cases in which nasal
access is difficult. It is important to have some endonasal
training and have an intimate knowledge of the nasal
anatomy before attempting this technique.Many investigators
use a light pipe inserted through the canaliculi to identify the
intranasal position of the sac. During our studies septoplasty
(SMR) to improve access to the axilla of the middle turbinate
was necessary in 46% of cases. It is important that the
ophthalmologist train in this area before attempting this
technique. This high percentage relates to the increased access
needed with this approach. Only minimal access is needed in
ENLDCR to remove the lacrimal bone.
An additional advantage of MENDCR was the preservation
of lacrimal pump function. This was easily visualised with the
endoscope by observing fluorescein being pumped into the
nose with each blink (see Fig 3). Previous studies have shown
that successful endonasal DCR patients are more likely to have
Figure 2 Marsupialised lacrimal sac. A, common canalicular
opening on lateral nasal wall. B, marsupialised lacrimal sac on
lateral nasal wall. C, opened agar nasi cell. D, middle turbinate. Figure 3 Fluorescein flow into the nose.
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positive scintillography when compared to successful external
DCR patients.9 23 The attachments of the orbicularis to the lat-
eral wall of the lacrimal sac are not disturbed with this
approach and this may help preserve some lacrimal pump
function..
CONCLUSIONS
For the past decade many types of endonasal approaches have
been tried. Generally the long term success rates have not
been equivalent to that achieved with external DCR. The tech-
nique we describe encompasses important differences to pre-
viously described methods. It involves creation of a large rhi-
nostomy and the preservation of lacrimal sac and nasal
mucosa to create mucosal flaps. This mucosal preservation and
apposition help to marsupialise the lacrimal sac onto the lat-
eral nasal wall.
Good anatomical knowledge of intranasal structures allows
accurate mucosa preserving surgery. Endoscopic skills are
necessary to ensure accurate and reproducible surgery.
The technique described has a success rate of 89% and the
anatomical success rate is 95%. These results are similar to
those obtained for both external DCR as well as for other
endonasal approaches.
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